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Abstract
Expression of HIV-1 genes is regulated at multiple levels including the complex RNA splicing and transport mechanisms. Multiple
cis-acting elements involved in these regulations have been previously identified in various regions of HIV-1 genome. Here we show that
another cis-acting element was present in HIV-1 env region. This element enhanced the expression of Gag when inserted together with Rev
response element (RRE) into a truncated HIV-1 genome in the presence of Rev. The enhancing activity was mapped to a 263-bp fragment
in the gp41 region downstream to RRE. RNA analysis showed that it might function by promoting RNA stability and Rev-dependent RNA
export. The enhancement was specific to Rev-dependent expression, since it did not enhance Gag expression driven by Sam68, a cellular
protein that has been shown to be able to substitute for Rev in RNA export function.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Expression of HIV-1 genes is regulated by several post-
transcriptional mechanisms including RNA splicing, stabil-
ity, transport, and translation. These mechanisms employ
multiple intragenic cis-regulatory elements, which have
been identified in different regions of the HIV-1 genome.
These elements include cis-acting repressive sequence
(CRS) or inhibitory/instability sequence (INS) (Cochrane et
al., 1991; Huffman and Arrigo, 1997; Mikaelian et al., 1996;
Reddy et al., 1995; Schwartz et al., 1992b), Rev response
element (RRE) (Huang et al., 1991), suboptimal splicing
signals (Dyhr-Mikkelsen and Kjems, 1995; Si et al., 1997),
and splicing enhancers and silencers (Amendt et al., 1994;
Jacquenet et al., 2001; Staffa and Cochrane, 1994, 1995;
Tange et al., 2001; Tange and Kjems, 2001). The env region
of HIV-1 contains CRS, RRE, a splice acceptor, and its
enhancer/silencer. Mapping of the CRS in env showed that
the CRS activity spanned most of the gp120 region with the
highest activity within about 1 kb upstream to RRE (Nasio-
ulas et al., 1994; Rosen et al., 1988). The CRS elements are
located not only in env but also in most structural genes,
such as gag, pol, and vif (Huffman and Arrigo, 1997; Reddy
et al., 1995; Schwartz et al., 1992b). Although a consensus
sequence has not been defined, CRSs are known to be
AT-rich (Schneider et al., 1997; Schwartz et al., 1992a). The
CRS in each gene is known to be self-sufficient and does not
need CRS in other parts of the genome to be functionally
active. However, it is not known whether a CRS in a
particular region exerts additional CRS effect on expression
of other genes that have their own CRSs. The splicing
regulatory sequences in the env region affect the efficiency
of the splicing that joins first and second exons of tat and
rev, thus, affecting the level of multiply spliced mRNA of
tat and rev. However they are not known to affect the
splicing efficiency of the upstream introns outside the env
region, which would affect the expression level of unspliced
and singly spliced RNA. The RRE, which is the binding site
of Rev, is required for the efficient expression of all Rev-
dependent unspliced or partially spliced mRNAs. Therefore,
except for the RRE, there is no known cis-regulatory ele-
ment in the env region that can affect expression of other
structural gene directly, although the splicing enhancer/
silencer may affect the level of Tat and Rev production, and
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therefore, may indirectly affect expression of other viral
genes. Because all the mRNAs for structural proteins con-
tain the env region, if an additional element is needed for the
global control of structural gene expression, it is likely to be
located within the env region. In this study, we asked
whether there was any sequence element in the env region
that affected the expression of gag directly via a cis-acting
mechanism when the levels of Tat and Rev were held
constant.
Results
Env subfragment up-regulated expression of Gag
We were looking for sequences in env region that could
exert a cis-regulatory activity over the Gag expression. To
do this, we divided an env clone of a HIV-1 subtype E
primary isolates (449) into 5 (from 5end to RRE, HxB2 nt
6225–8002) and 3 (from RRE to 3end, HxB2 nt 7769–
8793) subfragments. We cloned the subfragments into pHx-
AscNot replacing the tat, rev, vpu, env ORFs (Fig. 1). This
removal of tat and rev eliminated the difference in the
expression efficiency due to the variation of Tat and Rev
expression from the constructs. When the constructs were
cotransfected with pCMV-tat/rev/env into COS7 cells, the
construct that contained RRE and the 3 fragment (pHx-
3env) expressed a higher level of p24 than the constructs
that contained only RRE (pHx-RRE) or the 5 fragment and
RRE (pHx-5env) (Fig. 2A). This suggested that a cis-
enhancing sequence was present within the 3 subfragment
of env downstream to the RRE. To confirm that the higher
p24 level in supernatant represents higher expression of Gag
proteins in the cells, we performed Western blot analysis on
the cell lysate. Fig. 2B shows a Western blot analysis of
COS7 cells cotransfected with pHx-RRE, or pHx-RRE-
8609 (containing the 3 env sequences up to nt 8609 from
either the primary isolate 449 or the molecular clone HxB2)
and pCMV-tat/rev/env (or pCMV-tat and pCMV-rev).
Higher expressions of p55 Gag precursor, p41 Gag inter-
mediate, and p24 core antigen were observed in cells trans-
fected with pHx-RRE-8609. The levels of env expression
(from pCMV-tat/rev/env) were similar among cells that
were cotransfected with different constructs, suggesting that
the transfection efficiencies and the amounts of Rev protein
expressed were comparable. The transfection efficiencies
were also controlled by equal percentages of green fluores-
cent cells in one set of transfection, in which the reporter
plasmid pEGFP-N1 was cotransfected (data not shown).
The cis-enhancing sequence (CES) was mapped to a 263-
bp fragment in gp41 region, and deleting the overlapping
splice acceptor did not affect the CES function
The putative CES in the 3 part of env449 was further
mapped by serial truncation from both ends. As shown in
Fig. 3, the up-regulation of p24 expression was lost when
the fragment was truncated beyond nt 8220 from the 5 end
and nt 8483 from the 3 end. We therefore concluded that
the CES was located within the boundary of nt 8220–8483.
Because this region overlapped with the first 108 nucleo-
tides of the second exon of rev, it was possible that the
second exon of rev might play a role in the CES function.
To test this possibility, we deleted the splice acceptor of the
second exon of rev. The construct pHx-RRE-8220–
8483SA, in which the splice acceptor had been deleted,
showed a similar level of p24 expression as that of pHx-
RRE-8220–8483 (Fig. 3). This suggested that the splicing
that fused an upstream exon to the second exon of rev,
Fig. 1. Schematic representations of the plasmid constructs: The SalI-NotI fragment containing tat, rev, env ORFs of pHxB2 (A) was replaced with RRE (filled
box) to generate pHx-RRE (B), with 5 portion of env together with RRE to generate pHx-5env (C), or 3 portion of env together with RRE to generate
pHx-3env (D).
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which might produce a truncated Rev protein was not the
mechanism responsible for the p24 up-regulation.
To study whether CES activity was orientation-depen-
dent, we inserted the 8003–8609 fragment and the 8220–
8483SA fragment in the opposite orientation. This re-
sulted in constructs that expressed p24 at a level comparable
to expression from a construct without env subfragment
(Fig. 3). This indicated that the function of the CES was
orientation-dependent. The transfection efficiencies among
different constructs were controlled by cotransfection with
pEGFP-N1 in one set of experiments and shown to be
comparable (mean transfection efficiency  36.54%, SD 
2.27%). Adjusting the p24 level with transfection efficiency
did not change the level of difference among the constructs.
Because RRE has been shown to contain longer stem 1 than
that was originally described (Mann et al., 1994), we also
tested the function of the CES with the longer version of
RRE that has extended stem 1. In conjunction with the
extended RRE, the 8003–8609 fragment enhanced Gag
expression by 5- to 10-fold in the same fashion as with
shorter RRE (data not shown).
Because we used pCMV-tat/rev/env to supply both Tat
and Rev, expression in the absence of rev could not be
shown in Figs. 2 and 3. To show that the CES enhanced
rev-dependent expression, we used pCMV-tat and pCMV-
rev to supply the two proteins separately. As shown in Fig.
4, the p24 levels were under a detectable level in the ab-
sence of Rev for both pHx-RRE and pHx-RRE-8609. This
indicated that the CES enhanced rev-dependent expression
and not the basal expression independent of rev.
To confirm that this CES was not an unusual element
found only in this particular env sequence, we also made
similar constructs using env of HXB2 and fragments am-
plified from 10 primary isolates, which showed the same
positive-regulatory effect of the env fragment (Fig. 5). All
the primary isolates including 449 were identified as sub-
type E by C2V3 sequencing.
The env clone 449 was sequenced. The sequence showed
intact env, tat, rev open reading frames (ORFs). RRE, and
splice acceptor and contained no unusual mutation. The
truncated subfragments that lost the stimulatory function
were also sequenced and shown to have similar sequence as
compared to the original full-length env clone (data not
shown).
The CES enhanced cytoplasmic expression of Rev-
dependent RNA
As shown in Fig. 6, both unspliced and singly spliced
RNAs in the cytoplasm were more abundant in cells trans-
fected with pHx-RRE-8609 as compared to pHx-RRE. In
the nucleus, the unspliced RNA levels were comparable
between the constructs, but singly spliced RNA levels from
pHx-RRE-8609 were higher than those from pHx-RRE.
These suggested that the CES might function to promote
nuclear export as well as stability of the RNAs. Because in
our constructs all the second splice donors were removed,
multiply spliced RNA could not be generated and only
unspliced and singly spliced RNAs that contained RRE
were present. For pHx-RRE-8609 but not pHx-RRE the
second spliced acceptor of tat/rev/nef downstream to RRE
was present. A singly spliced RNA species using the major
splice donor in front of gag ORF and this splice acceptor
was detectable from pHx-RRE-8609 at a low level only
Fig. 2. The p24 expression was enhanced by a 3 fragment of env. The
constructs pHx-RRE, pHx-5env, and pHx-3env were cotransfected with
pCMV-tat/rev/env into COS7 cells. The p24 levels in supernatants were
measured at day 3 posttransfection (A). Western blot analysis of the
transfected cell lysates showed increased in expression of Gag proteins in
cells transfected with pHx-RRE-8609 (containing an env fragment from
RRE to nt 8609) from env clone 449 and from HxB2 (lane 2, 3, 5) as
compared to the constructs containing RRE alone (lane 1) (B).
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after extension of PCR cycles from 25 to 35 cycles (data not
shown).
It is known that CRS not only suppresses expression of
CRS-containing RNA in the absence of Rev but also has a
positive effect on Rev-dependent expression (Mikaelian et
al., 1996). Because CES also increased the efficiency of
Rev-dependent expression, it was possible that CES might
have done so by providing additional CRS activity to the
constructs. To exclude this possibility, we inserted the p17
gag CRS into the same position in pHx-RRE immediately
downstream to RRE. The construct pHx-RRE-p17 ex-
pressed a low level of p24 comparable to pHx-RRE when
cotransfected with pCMV-tat/rev/env into COS7 cells (data
not shown). This indicated that having additional CRS did
not increase Rev-dependent expression of a construct that
already contained CRS.
The CES did not enhance Sam68-dependent activation
Sam68 is a cellular protein that was recently reported to
be able to substitute for as well as enhance Rev in the RNA
export function (Reddy et al., 1999, 2000a, b). We ques-
tioned whether Sam68 could cooperate with the CES in the
same manner as rev. As shown in Fig. 7, the p24 levels in
cotransfections with Sam68 were not different between
pHx-RRE and pHx-RRE-8609. This indicated that the CES
did not function in a Sam68-dependent expression.
Fig. 3. The CES in the env region was mapped to a 263-bp fragment downstream to RRE. The hatched boxes represent the RRE; open boxes represent
truncated fragments of env. The numbers at the ends of open boxes represent the nucleotide numbers that mark the boundaries of the fragment. The filled
box represents the fragment inserted in the opposite orientation. The bars on the upper panel are the p24 level in supernatant of COS7 cells cotransfected
with each construct and pCMV-tat/rev/env. SA indicates deletion of the splice acceptor of the second exon of rev in the constructs.
Fig. 4. The CES enhanced rev-transactivation. COS7 cells were cotrans-
fected with either pHx-RRE or pHx-RRE-8609 and pCMV-tat with (solid
bars) or without pCMV-rev (open bars) by electroporation. The amount of
total DNA was equalized by adding pGEM-T empty vector (Promega).
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Discussion
Posttranscriptional control of HIV-1 gene expression is
complex and involves multiple regulatory mechanisms. Al-
though the major cis-regulatory elements involved in the
process, such as RRE and CRS/INS, have been well char-
acterized, other less prominent regulatory elements might
have been overlooked. We describe here a regulatory ele-
ment in HIV-1 env region that can up-regulate the expres-
sion of Gag proteins. Because the CES did not affect the
level of unspliced RNA in the nucleus while it increased the
level in cytoplasm, it might function by facilitate Rev-
dependent RNA transport. However, the CES also increased
singly spliced RNA levels both in nucleus and cytoplasm.
This suggested that the CES might also promote the stability
of the RNA. The presence of gag CRS may explain the lack
of this stability effect in unspliced RNA. Because no matter
whether CES was present or not, unspliced RNAs already
contained gag CRS, which might promote RNA stability in
the presence of Rev. The increase of both unspliced and
singly spliced RNAs indicated that the CES did not function
by controlling splicing efficiency.
We also found that the up-regulation by the CES oc-
curred only in the presence of Rev but not Sam68. Both Rev
and Sam68 bind to RRE but export RRE-containing RNA
via different mechanisms (Reddy et al., 1999). Our data
therefore suggested that the enhancement of RNA transport
by CES probably occurred through the Rev-specific export
pathway.
Because CRS also facilitates Rev-dependent RNA trans-
port, it is plausible to suspect that the CES might be in fact
a CRS. However, inserting a CRS from gag p17 into the
same location did not enhance the expression of gag. The
CES was therefore not interchangeable with the p17 CRS.
Furthermore, the location of the CES described in this study
was different from the location of CRS mapped in previous
studies (Nasioulas et al., 1994; Rosen et al., 1988). This
further supports the finding that the CES belonged to a
different type of regulatory element.
All 11 env clones from subtype E primary isolates and
the clone from HxB2 showed comparable CES activity,
suggesting that it was important for the fitness of the viruses
and may be a conserved element found in most HIV-1
isolates.
The region, in which the CES was mapped to, contained
multiple AT-rich sequences, splice acceptor of the second
exon tat and rev and its enhancers and silencer. Although
the splice acceptor itself was dispensable for the CES ac-
tivity, the sequences surrounding the splice acceptor are
known to be binding sites of several nuclear proteins im-
plicated in splicing control. These proteins and their binding
sites might be multifunctional and involved in some other
functions unrelated to splicing control. Whether these bind-
ing sites contribute to the function of CES is being studied.
Materials and methods
Env clones and DNA constructs
An HIV-1 env clone, 449, was obtained from a primary
virus isolated from a pregnant woman in 1995 at Siriraj
Hospital in Bangkok. The Env gene was amplified by a
nested PCR from cultured infected peripheral blood mono-
nuclear cells (PBMCs) as previously described using env A,
env N as outer primers and env B and env M as inner
primers (Gao et al., 1994). The restriction sites AscI and
NotI were then introduced immediately up- and downstream
to env ORF, respectively, by PCR using primers AscI
Fig. 5. The bars represent the p24 level in supernatant of COS7 cells transfected with the constructs carrying RRE alone or RRE and the env subfragment
(8003–8609) from HxB2, primary isolate 449, or other subtype E primary isolates.
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(GGCGCGCCATGAGAGTGAAGGAGACACAGA) and
NotI (GCGGCCGCTTATACCAAAGCCCTTTCTA).
Diagrams of plasmid constructs are shown in Fig. 1. To
generate pHx-AscNot, two unique sites, AscI and NotI, were
introduced into the prototype HIV-1 molecular clone HxB2
directly up- and downstream to the env ORF. The env
region in this construct was then swapped by env clones of
449. The SalI-NotI fragment carrying tat, rev, and env ORFs
from the chimeric constructs were then cloned into
pCMV2 (Clontech) by replacing LacZ gene to generate
pCMV-tat/rev/env.
pHx-RRE, pHx-5 env, pHx-3 env constructs were gener-
ated by replacing the SalI-NotI fragment of the pHx-AscNot
with either RRE fragments or 5 or 3 subfragments of env
449. The RRE, 5env, and 3env subfragments were PCR-
amplified from the env clone using the primer pairs RRE-Sal
(TCTGACAGTCGACAAAAGAGCAGTGGGAATAGG)
and RRE-Not (TGACAGCGGCCGGAGCAGCCCC
AAAGT), AscI and RRE-Not, RRE-Sal and NotI, respectively.
Serial 3 truncated subfragments of 3env449 were generated
by PCR using the primer RRE-Sal together with 8609
(ATATTTGAGGCCTTCCCACC), 8483 (TAAGAATC-
CGCTCACTAATC), 8304 (CTATTAAACCTCCTAC-
TATC), or 8194 (TTCATCCCTGTCCTGCTGGT). The frag-
ments were then cloned into the pHx-AscNot replacing SalI-
NotI fragment generating pHx-RRE-8609, pHx-RRE-8483,
pHx-RRE-8304, and pHx-RRE-8194, respectively. Serial 5
truncated subfragments of the 3env were generated by PCR
using the primer 8609 XhoI (ACCGGCTCGAGATATTT-
GAGGCCTTCC) together with 8111 (AGAATGG-
Fig. 6. A representative HIV-RNA analysis in nuclear (lanes 1–3) and cytoplasmic fraction (lanes 4–6) of COS7 cells cotransfected by pCMV-tat/rev/env
and the constructs carrying RRE alone (pHx-RRE) (lanes 1, 4) or RRE and CES (pHx-RRE-8609) from the env clone 449 (lanes 2, 5) or HxB2 (lanes 3,
6). Lane 7 shows reactions of nuclear RNA from pHx-RRE-8609 without RT as controls for DNA contamination, and lane 8 was blank amplifications. The
RT-PCR products of GADPH mRNA from each RNA preparation were shown in the lower gel (A). The transfection efficiencies between the constructs with
and without the env subfragment were controlled by cotransfection with pEGFP-N1 and shown to be comparable (data not shown). The quantitative nature
of the RT-PCR for HIV-1 RNA is shown in a set of reactions performed on threefold serial diluted RNA from COS7 cells transfected with pHx-RRE-8609
and pCMV-tat/rev/env (B).
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GAGAGAGAAATTA), 8220 (TGGGCAAGTCTGTG-
GAATTG), or 8322 (GCTGTGCTTTCTATAGTG(A)AA).
The fragments were then cloned into the pHx-RRE, replacing
the NotI-XhoI fragment. Finally subfragments 8220–8483 and
8322–8483 were amplified from the 449 env and cloned into
the pHx-RRE at the NotI site. The pHxB2 and 10 other pri-
mary isolates from HIV-infected persons in Bangkok were
used to generate subfragments of env by PCR using the primer
Not 8003 (ATAAGAATGCGGCCGCAGGACTTT-
GGGGCTGCTCTG) and 8609 XhoI. These 8003–8609 frag-
ments from HxB2 and 10 subtype E primary isolates were then
cloned into the pHx-RRE replacing NotI-XhoI fragment. A p17
fragment containing CRS of gag was PCR amplified using the
primers p17up (AGGAGAGAGATGGGTGCGAG) and
p17down (GGGTAATTTTGGCTGACCTG). The p17 frag-
ment was then cloned into pHx-RRE at NotI site to generate
pHx-RRE-p17.
The deletion of the splice acceptor of the second exon of
rev was made by site-directed mutagenesis on the 8220–
8483 fragment that was cloned into pGEM-T Easy (Pro-
mega). The mutagenesis was done using the primer SA
(GAGTTAGGCAGGGATGTCGACACCCCTTCCCAT-
CA) and a Muta-Gene Phagemid In Vitro Mutagenesis kit
(Bio-Rad). This deleted 19 bases surrounding the splice
acceptor. The 8220–8483SA fragment was then cloned
into pHx-RRE at the NotI site to generate pHx-RRE-8220–
8483SA.
The exonl of tat was PCR-amplified from HxB2 using
primers tat-upstream (GTCGACGAGCAAGAAATG-
GAGCCAGT) and tat-downstream (GGACCACACAAC-
TATTGCTATTATT) and cloned into pCMV2 replacing
LacZ gene to generate pCMV-tat. Both exons of rev were
amplified from infected PBMCs of a primary isolate (W56)
by a nested PCR. The outer primers were TatIF (TTTCA-
GAATTGGATGCCGACATA) and envM, and the inner
primers were revI-up (GTCGACCATCTCCTATGGCAG-
GAAGA), revI-down (GGGAAGGGGTTGC TTTGG-
TATAGGATTTTGATG) for exonl; and rev2-up (ATAC-
CAAAGCAACCCCTTCCCATCATCAGAA), rev2-down
(TCTCCAAGCTCCTTGTGCTA) for exon2. The two ex-
ons were then fused by spliced-overlapping extension to
make the complete rev ORF, which was then cloned into
pCMV2 replacing LacZ gene to generate pCMV-rev.
Transfection and expression analysis
The DNA constructs were transfected into COS7 cells
using DMRIE-C transfection reagent (Gibco-BRL). Plas-
mid DNA in a total of 6 g (diluted in 0.5 ml of serum-free
MEM) and 8 l DMRIE-C reagent (diluted in 0.5 ml of
serum-free MEM) was mixed and incubated at room tem-
perature for 45 min and then added to COS-7 cells in
six-well plates. After 4 h incubation, 2 ml MEM supple-
mented with 10% fetal calf serum was added to the cells.
The transfection experiments were run in quadruplicate.
The supernatant was harvested on day 3 and assayed for p24
level using an antigen-captured ELISA (Vironostika, Or-
ganon Teknika). At the same time, cells were harvested for
Western blot and RNA analysis. In some of the experi-
ments, a green fluorescent protein reporter plasmid
pEGFP-N1 (Clontech) was cotransfected, and the percent-
age of green fluorescent cells was counted by flow cytom-
etry to control for the transfection efficiency.
For Western blot analysis, transfected cells in 25-cm2
flasks were lysed in 100 l RIPA buffer (50 mM Tris–Cl pH
7.2, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1%
deoxycholate), vortexed, incubated on ice for 15 min, and
centrifuged at full speed in a microcentrifuge at 4°C for 5
min. Twenty microliters of the lysate was mixed with 4
loading buffer (0.2 M Tris–Cl pH 6.8, 0.4 M dithiothreitol,
8% SDS, 0.4% bromphenol blue, 40% glycerol) and loaded
onto 15% polyacrylamide gel. After electrophoresis the gels
were soaked in two changes of transfer buffer (39 mM
glycine. 48 mM Tris pH 8.3, 0.07% SDS, 20% methanol)
before blotting onto nitrocellulose membrane by semidry
electroblotting. The HIV-1 proteins on the membrane were
then detected with pooled HIV-1 seropositive human sera,
biotinylated anti-human immunoglubulin, and streptavidin-
horseradish peroxidase complex. The signal was visualized
using diaminobenzidine (DAB) substrate.
Cytoplasmic and nuclear RNA were extracted as de-
scribed (Sambrook et al., 1989). Briefly, on day 3 trans-
fected COS7 cells were harvested and lysed in 50 l cyto-
plasmic lysis buffer (0.14 M NaCl, 1.5 mM MgCl2, 10 mM
Tris–Cl pH 8.6, 0.5% Nonidet P-40, 1 mM dithiothreitol,
Fig. 7. The CES functioned in a rev-specific manner. The open and filled
bars represent p24 level in supernatant of COS7 cells cotransfected with
pHx-RRE or pHx-RRE-8609, respectively, and either pCMV-tat and
pCMV-rev; or pCMV-tat and pcDNA3.1-SAM68; or pCMV-tat and
pCMV-rev and pcDNA3.1-SAM68.
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and 1000 U/ml RNase inhibitor) at 4°C for 5 min and then
centrifuged at 12,000 rpm for 90 s at 4°C in a microcentri-
fuge. The supernatant, containing cytoplasmic RNA, and
the nuclear pellet were separated and RNA was extracted
from each fraction using TRIZOL reagent (Gibco-BRL),
treated with RNase-free DNase, and reextracted with
TRIZOL. RT-PCR was then performed on 1 g of extracted
RNA using random hexamers for RT reaction and the prim-
ers BSS (GGCTTGCTGAAGCGCGCACGGGAAGAGG)
and GAGA (AACTGCGAATCGTTCTAGCTCCCTG) for
unspliced HIV-1 RNA (Saltarelli et al., 1996), BSS and
R5733 (CTTCCACTCCTGCCCAAGTATCCCC) (HxB2
nt 5733–5709) for singly spliced HIV-1 RNA in 25 cycles
of PCR. These primer sets were designed to anneal up-
stream to SalI site. They therefore cannot amplify the viral
RNA from pCMV-tat/rev/env that was used in the cotrans-
fection. Reactions without reverse transcriptase enzyme
were run in parallel to control for the contamination of
DNA. To show the quantitative nature of the RT-PCR,
three-fold serial diluted RNAs from COS7 cells cotrans-
fected with pHx-RRE-8609 and pCMV-tat/rev/env were
subjected to RT-PCR under the same condition. The
GADPH mRNA was detected by RT-PCR in parallel to
control for the quality of RNA as described (Nishimori et
al., 1997).
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